Clinical Trial Detail

NCT ID NCT01663272
Title A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Michigan Cancer Center
Indications

pancreatic carcinoma

Therapies

Cabozantinib + Gemcitabine

Age Groups: adult

No variant requirements are available.